Skip to content

Clinical observation and study of 0.05% atropine inhibiting myopia

Clinical observation and study of 0.05% atropine inhibiting myopia

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100043506
Enrollment
Unknown
Registered
2021-02-21
Start date
2021-04-01
Completion date
Unknown
Last updated
2023-03-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Myopia

Interventions

Group A :Once a night
Group B :2 times a week
Group C:1 time a week

Sponsors

Aier Institute of Optometry and Vision Science
Lead Sponsor

Eligibility

Sex/Gender
All
Age
4 Years to 12 Years

Inclusion criteria

Inclusion criteria: 1. Subjects aged 4-12 years (including 4 and 12 years old), regardless of gender; 2. Subjects whose best corrected visual acuity is not lower than the lower limit of normal value of corresponding age; 3. Subjects with ametropia (according to the results after mydriasis) The equivalent spherical leniency (MSE) of each eye is less than - 1.0d; Astigmatism = 0.5d in the past year; 4. Subjects with IOP < 21 mmHg.

Exclusion criteria

Exclusion criteria: 1. Subjects whose best corrected visual acuity is lower than the lower limit of normal value of corresponding age; 2. Subjects who used at least one of the following myopia prevention and control methods before enrollment: Atropine eye drops (including any concentration); Corneal contact lens; Multifocal frame glasses 3. Subjects allergic to atropine; 4. Children with other complex eye diseases (such as amblyopia, strabismus, corneal scar, cataract, true microphthalmos, glaucoma or ocular tumor); 5. Subjects with severe systemic diseases; 6. Subjects with history of eye surgery and trauma.

Design outcomes

Primary

MeasureTime frame
Diopter;Vision;Eye axis;Corneal curvature;

Secondary

MeasureTime frame
Adjustment function;Eye position;Fusion function;Color vision function;optical coherence tomography, OCT;Fundus;Tear quality;Pupil;Intraocular pressure;Eye behavior data;examination of visual electrophysiology;

Countries

China

Contacts

Public ContactXiaoning Li

Aier Institute of Optometry and Vision Science

lixiaoning@aierchina.com+86 18975897052

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Aug 16, 2026